There are parts of healthcare that feel abstract and parts that feel very immediate. Care delivery is very immediate.
Hospitals, surgery centers, rehab operators, and behavioral health providers do not need a hot market to matter.
They need patients, procedures, and enough labor stability to keep the operating room from feeling like a scheduling puzzle designed by a hostile deity.
That is what makes this theme attractive now.
Warning Signs Emerging (Sponsored)
No one believed Whitney Tilson when he predicted the collapse of Bear Stearns and Lehman Brothers. Or when he went on 60 Minutes exposing a company of poisoning its own customers.
(The stock fell nearly 80%.) Now he has a new warning about what's REALLY around the corner for America's most beloved tech companies.
Watch for free here.
Theme: Care Delivery, The Procedure Pipeline Keeps Moving
This setup works because care gets delayed, but usually not forever. Elective procedures can slip a quarter.
They rarely vanish. Higher-acuity demand, rehabilitation, behavioral health, and outpatient surgery all still have a reason to exist, even when the market is obsessed with something louder.
What’s Driving It
The large hospital and care-delivery operators have been putting up solid numbers. HCA reported fourth-quarter 2025 revenue up 6.7% to $19.5 billion and adjusted EBITDA up 10.8%.
Tenet reported fourth-quarter 2025 net operating revenue up 7.3% and gave 2026 adjusted EBITDA guidance of $4.485 billion to $4.785 billion.
UHS reported same-facility acute-care revenue up 6.9% and behavioral same-facility revenue up 7.2% in the fourth quarter.
Encompass Health reported 2025 revenue up 10.5% and adjusted EBITDA up 14.9%, while also issuing 2026 guidance.
Here is the chain reaction:
Procedure demand remains active → hospitals and surgery centers keep beds and rooms full
Rooms stay full → revenue visibility improves
Revenue visibility improves → labor pressure matters less than it did at the peak
Cleaner operating leverage → margins recover
Better margins and cash flow → buybacks, debt reduction, and expansion look more realistic
What Could Go Right
The best version of this theme is not explosive. It is orderly.
Volumes stay healthy, staffing stays manageable, and operators keep showing they can grow without tripping over labor or payer mix.
That is especially helpful for names like HCA and Encompass, where execution matters as much as demand.
Surgery Partners also gives you a nice outpatient angle, with same-facility revenue up 3.5% in the fourth quarter of 2025 and a new share repurchase program announced alongside 2026 guidance.
What Could Go Wrong
Labor is still not free. Reimbursement is still not generous. Regulatory issues, payer mix shifts, and local market softness can still create ugly quarters.
This group also tends to get less love when the market is chasing faster-growing healthcare stories, even if the fundamentals are doing just fine.
So this is a theme where the businesses can be working before the stocks get any respect for it.
HCA Healthcare (HCA)
What it does: Large hospital operator with broad exposure to inpatient and outpatient care.
Why it fits: HCA is the anchor name in the basket because it keeps producing large-scale evidence that demand is still there.
Fourth-quarter 2025 revenue rose 6.7% to $19.5 billion, net income rose 30.6%, and adjusted EBITDA rose 10.8%.
The company also issued 2026 guidance, which helps make the setup feel current instead of theoretical.
What could go right:
Procedure and acuity trends stay strong
Operating leverage keeps helping margins
Cash flow supports continued capital returns
Scale gives the company room to manage through localized issues better than smaller peers
What to watch next: Admissions, same-facility revenue trends, and whether labor and payer mix stay manageable enough for guidance to hold.
Risk: When expectations rise, even a decent quarter can get treated like a disappointment if volumes or margins wobble.
Tenet Healthcare (THC)
What it does: Hospital and ambulatory care operator with meaningful outpatient and surgery-center exposure.
Why it fits: Tenet gives you a nice split between traditional hospitals and the more flexible outpatient side.
Fourth-quarter 2025 net operating revenue rose 7.3%, adjusted EBITDA improved, and 2026 adjusted EBITDA guidance came in at $4.485 billion to $4.785 billion.
What could go right:
Better payer mix and outpatient strength support margins
Ambulatory exposure gives the company more flexibility than pure hospitals
Cash flow and guidance improve investor confidence
The market rewards the cleaner earnings profile if execution stays tight
What to watch next: Ambulatory momentum, margin quality, and whether guidance proves conservative instead of optimistic.
Risk: Hospital names can still get hit by labor, reimbursement, or market-specific softness.
The Access Shift (Sponsored)
For decades, one type of investment was reserved for the ultra-wealthy.
Then Executive Order 14330 changed everything — opening it up to ordinary investors.
Now you can access this booming opportunity for less than $20.
Universal Health Services (UHS)
What it does: Acute care hospitals plus a major behavioral health platform.
Why it fits: UHS gives you two demand streams in one name. Its fourth-quarter 2025 same-facility acute care revenue increased 6.9%, and same-facility behavioral revenue increased 7.2%.
That kind of dual-engine setup is useful when you want care delivery without relying on one pocket of the system.
What could go right:
Behavioral health remains a durable growth support
Acute-care revenue stays healthy enough to support the broader story
Better balance between segments reduces dependence on one operating environment
Investors start giving more credit to the behavioral side
What to watch next: Same-facility metrics and whether management can keep the business looking balanced instead of locally choppy.
Risk: UHS can still see regional volatility, especially in acute care, which can muddy the cleaner long-term setup.
Surgery Partners (SGRY)
What it does: Short-stay surgical facilities and outpatient procedure centers.
Why it fits: Surgery Partners is the outpatient-growth angle.
Fourth-quarter 2025 revenue rose 2.4% to $885 million, same-facility revenue rose 3.5%, and the company set 2026 guidance while authorizing a share repurchase program.
What could go right:
Same-facility cases and revenue per case keep trending higher
Outpatient procedures continue taking share
Capital allocation and buybacks help the stock story
Investors reward a more focused way to play procedures without full hospital exposure
What to watch next: Same-facility growth, EBITDA trajectory, and whether the outpatient model keeps looking more efficient than the legacy hospital setup.
Risk: Lower scale means less room for error if reimbursement or case mix shifts unexpectedly.
Built For Higher Crude (Sponsored)
Oil has moved above $100 a barrel as tensions in the Middle East continue to reshape expectations across global energy markets.
While daily headlines can drive sharp swings, the bigger story may be what higher crude prices mean for select energy companies with strong cash flow and operating leverage.
Zacks has outlined three oil stocks that may be well positioned if elevated prices persist.
Read the report.
*The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. Access grants you a comprehensive list of all open and closed trades.
*This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service".
Poll: Which type of system feels the most outdated but still everywhere?
Encompass Health (EHC)
What it does: Inpatient rehabilitation hospitals and related post-acute care services.
Why it fits: Encompass gives the basket a post-acute and rehab angle, which helps diversify the procedure story.
The company said 2025 revenue increased 10.5% and adjusted EBITDA grew 14.9%, while also highlighting bed additions and 2026 guidance.
What could go right:
Aging demographics keep demand supportive
Capacity additions create growth without needing heroic assumptions
Margin performance remains strong as labor stabilizes
The market starts appreciating rehab as a cleaner-growth niche inside care delivery
What to watch next: Occupancy, capacity growth, and whether guidance stays comfortable as the year progresses.
Risk: If labor tightens again or referral patterns soften, the growth story can look less smooth.
Want to make sure you never miss a stock recommendation?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell. Email’s great. Texts are faster.
This theme does not need a roaring economy.
It just needs patients to keep moving through a healthcare system that still has real backlogs, real needs, and real operators that have gotten better at managing labor and throughput.
Watch volumes, guidance, and margin progression.
If those stay solid, care delivery can remain one of the steadier ways to play healthcare without leaning on biotech miracles or drug-pricing drama.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
